Parabilis Medicines, Inc. Common Stock (PBLS) — Financial Flexibility Index
Parabilis Medicines, Inc. Common Stock (PBLS) has a Financial Flexibility Index of -0.35x as of March 2026. Free cash flow of $-48.83 Million (operating CF $-49.20 Million minus capex $369.00K) represents 0% of total liabilities ($139.95 Million). For the full cash flow conversion analysis, see Parabilis Medicines, Inc. Common Stock operating cash flow efficiency.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Parabilis Medicines, Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Parabilis Medicines, Inc. Common Stock across 2 annual periods. Check Parabilis Medicines, Inc. Common Stock tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Financial Flexibility Index for Parabilis Medicines, Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for Parabilis Medicines, Inc. Common Stock. Explore PBLS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.27x | $-123.41 Million | $-123.71 Million | $97.34 Million | ▼ -14.5% |
| 2024 | -1.11x | $-102.73 Million | $-103.61 Million | $92.81 Million | — |